CTLA4 and triple-A syndrome: Although a possible role of the coinhibitory molecule CTLA-4 in the protection against atherosclerosis has been suggested12,14, its role in the development of atherosclerosis-related cardiovascular diseases such as AAA remains completely unknown so far.